The Prevent Anal Cancer Self-Swab Study

NACompletedINTERVENTIONAL
Enrollment

253

Participants

Timeline

Start Date

January 9, 2020

Primary Completion Date

August 31, 2023

Study Completion Date

August 31, 2023

Conditions
Anal Cancer
Interventions
BEHAVIORAL

Home-based human papillomavirus (HPV) DNA screening

Persons randomized to arm 1 will receive an HPV DNA home-based collection kit in the mail at 0 and 12 months.

BEHAVIORAL

Clinic-based human papillomavirus (HPV) DNA screening

Persons randomized to arm 2 will attend a clinic where a clinician will collect the DNA specimen at 0 and 12 months.

Trial Locations (1)

53202

Medical College of Wisconsin, Milwaukee

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

The University of Texas Health Science Center, Houston

OTHER

collaborator

M.D. Anderson Cancer Center

OTHER

lead

Medical College of Wisconsin

OTHER

NCT03489707 - The Prevent Anal Cancer Self-Swab Study | Biotech Hunter | Biotech Hunter